Success Metrics

Clinical Success Rate

40.0%

Based on 2 completed trials

Completion Rate

40%(2/5)

Active Trials

1(13%)

Results Posted

0%(0 trials)

Terminated

3(38%)

Phase Distribution

Ph phase_3

25%

Ph phase_2

25%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

2(33.3%)

Phase 3Large-scale testing

2(33.3%)

Phase 4Post-market surveillance

2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

2 of 6 finished

Non-Completion Rate

66.7%

4 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(4)

Detailed Status

Terminated3

Completed2

Recruiting1

Withdrawn1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

40.0%

Most Advanced

Phase 4

Trials by Phase

Phase 22 (33.3%)

Phase 32 (33.3%)

Phase 42 (33.3%)

Trials by Status

terminated338%

completed225%

recruiting113%

withdrawn113%

not_yet_recruiting113%

Recent Activity

1 active trials

Showing 5 of 8

recruitingphase_2

Trial of Therapeutic Hypothermia in Patients With ARDS

NCT04545424

terminatedphase_3

Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome

NCT04012073

terminatedphase_4

Clinical Trials (8)

Showing 8 of 8 trials

NCT04545424Phase 2

Trial of Therapeutic Hypothermia in Patients With ARDS

Recruiting

NCT04012073Phase 3

Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome

Terminated

NCT02902055Phase 4

Paediatric Ards Neuromuscular Blockade Study

Terminated

NCT03962725Phase 4

Avoiding Neuromuscular Blockers to Reduce Complications

Terminated

NCT04028362

Neuromuscular Blockade in the Intentive Care Unit, an Observational Study.

Completed

NCT03585348

Provider Variability in the Use of Neuromuscular Blocking Drugs and Reversal

Completed

NCT03376854Phase 2

Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS

Withdrawn

NCT04096144Phase 3

Comparison of Sugammadex and Neostigmine During PACU Stay

Not Yet Recruiting

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8